2020 ASTRO Annual Meeting

Abstract Presentation Formats

October 25-28, 2020
Miami Beach Convention Center
Miami Beach, Florida

Please see below the presentation format you prefer when submitting your abstract:

Oral or Poster

Abstract will be considered for oral, quick-pitch or poster viewing.

Poster Only

Abstract will be considered for digital poster viewing only.

Please note that abstracts may be re-categorized by the Track Chairs as deemed appropriate.

Presentation Categories

Plenary Session

Three to five top-rated abstracts are accepted for the Plenary Session and will be offered in an unopposed general assembly. The Plenary Session includes didactic presentations highlighting abstracts of scientific significance deemed to have the highest merit and greatest impact on radiation oncology research and practice. Experts in the field will serve as discussants to place research findings into perspective.

Clinical Trials Session

The Clinical Trials Session will be offered in an unopposed general assembly. Research submitted from significant clinical trials and trials in progress including interim results may be selected for this special session. Previously presented results may be considered if they are deemed relevant by the program planning committee.

Oral Scientific Sessions

Oral scientific sessions provide didactic presentations of scientific research. Accepted abstracts are scheduled in 60- and 75-minute sessions. Each presenter is given seven minutes to present his or her paper immediately followed by a three-minute question and answer period. Oral presentations are grouped together by track. Experts in the field (discussants) are chosen to provide comprehensive themed discussions of the findings from predetermined abstracts.

Quick Pitch Sessions

During the 2019 Annual Meeting we piloted a new session format called Mini-oral presentations. The format has been improved for 2020 and re-named Quick Pitch sessions and will be organized as follows: Presenters summarize outcomes while highlighting key takeaways from their research in a fast-paced format. Moderators will oversee the session to ensure presenters stay within their allotted presentation time and engage the audience during the Q&A period. Presenters will be limited to five minutes each and no more than five slides (title and disclosure slides are not included in slide count) and are encouraged to include only critical information. The intent is to provide a clear and concise takeaway message and allow for discussion between the presenter and the audience at the end of each session.

Poster Viewing Q&A Sessions

Approximately 2,000 digital posters will be on display in the Innovation Hub (Exhibit Hall). Posters will be grouped by disease site, and all poster authors will have the opportunity to provide a brief overview of their poster during a scheduled time in one of five Poster Viewing Q&A sessions. When not in session, the poster stations are available for poster browsing. Posters are searchable by keyword, presenter name, institution or poster number.